Interactive Publications
New Content Coming Soon!
Advertisement
Advertisement
Trending on Urology Times
1
CHMP recommends perioperative enfortumab vedotin plus pembrolizumab for MIBC
2
FDA grants RMAT designation to EG110A for neurogenic detrusor overactivity
3
FAQs: The 2026 AUA Guideline on Medical Management of Kidney Stones
4
PSMA-PET in clinical practice: Juan Gómez Rivas, MD, on barriers to access
5
